Search Results: therapeutic (168)

SanjayGupta.WikiCommons-DND523.jpg
Wikimedia commons/Dnd523.
Dr. Sanjay Gupta.

Arguably the most well-known doctor in the United States this week has announced that he is now in favor of legalizing medical cannabis and that he was wrong to speak out against medical marijuana in the past.
CNN chief medical correspondent Dr. Sanja Gupta says that five years ago, the research he was seeing just wasn’t there to prove that cannabis was a beneficial substance in America. At the time, Gupta rallied against cannabis, even penning an article in 2009 titled “While I Would Vote No on Pot”. But he now says his position was flawed, and it was mostly at due to his own willful ignorance on the matter.

12647199_546498392176755_1397639000356818163_nCourtesy of Lily Farm Fresh Skin Care

“My whole life lately seems to be about hemp,” says Lily Morgan. And for good reason: The founder of Colorado-based skin care company Lily Farm Fresh Skin Care has owned and operated eighty acres of farmland to supply her own production in Keenesburg, Colorado, for over thirty years, Now nearly 90 percent of it is devoted to hemp.

Morgan, who also owns an additional 170-plus acres spread throughout the state, has been making cleansers, moisturizers, toners, lip balms and other products for her certified organic skin care line since 1986. But she’s recently shifted, jumping on the CBD bandwagon and growing hemp for her new CBD-infused line of therapeutic lotions.

aa-big-pharma-pills-and-money-thumb-300x225.jpegadmin | Toke of the Town

They opposed REC sales in Arizona.

Here’s your daily dose of pot news from the newsletter WeedWeek.

Several former executives of Insys Therapeutics, which sells the powerful opiate fentanyl, were arrested accused of “ bribing doctors, defrauding insurance companies, and fueling America’s opioid addiction crisis.” Insys contributed to successfully defeat Arizona’s November REC vote.

GW Pharmaceuticals reported some “pretty grim” quarterly numbers, but it could benefit from its anti-epilepsy experimental drug Epidolex which is in late stage clinical trials.

Bloomberg suggests there’s a Canadian pot-stock bubble.

Legalization in more states could depress California’s export market. And in another interesting piece by Madison Margolin, California’s “extract artisans” now have some legal protections from meth-lab laws.

Vice dives into regulatory tech which it calls the “ cannabis surveillance state.

Home grow system Leaf raised $2M.

Celebrity-branded weed costs about 24% more than unbranded. Forbes asks if the trend has gone too far.

Commercial landlords in northern California prepare for legalization.

Quartz profiles marketing company Octavia Wellness which throws pot parties for seniors.  The art world is joining efforts to re-brand cannabis.

The Denver Post’s Cannabist won most influential media source at the cannabis business awards.

A new study in Pharmacological Research, by Czech and Italian researchers, found that pot is an aphrodisiac. Read the study here.

Another study found that marijuana use may damage eyesight.

New York state wants patients to be able to access MED in hospitals. A study found that cannabis users have lower in-hospital mortality rates.

In an effort to reduce opioid use, Oregon wants opioid patients monitored for marijuana use. The health agency view on marijuana vis a vis opioid use is unclear.

The world’s first clinical trial to test MED for chemotherapy patients is beginning in Australia.

A device developed by Israeli start-up distributes “ nano-droplets” of CBD as a nutraceutical to relieve inflammation and pain is on sale in the U.S. KKTV looked at the cannabis research happening at Colorado State-Pueblo.

The U.S. is lagging Israel and other countries in cannabis research.

The Washington [state]CannaBusiness Association is starting a fund to support MED access for the needy.

 

3998139338_f060d54552_oMartijn

Want to design your own high? Pay attention to the newest area of cannabis research: terpenes. These essential oils give each cannabis strain the unique smell, flavor and taste that you’ve come to love (or hate). Terpenes also offer special medicinal and therapeutic benefits that help with everything from insomnia to infections to depression. Here are the top ten things you need to know about terpenes:

 

surterra-therapeuticsSurterra Therapeutics

With the looming November 2 vote on Amendment 2, which would expand medical marijuana in Florida for specific diseases and conditions, one thing is clear: Weed is a polarizing topic. As New Times reported in August, according to one of the most respected marijuana-usage surveys in America, roughly half the residents in Miami-Dade and Monroe Counties think smoking weed once a month is “harmful” and should be avoided. The other half rallied for legalization in our Facebook comments.

Although voters disagree, businesses are preparing for a yes vote on Amendment 2. Surterra Therapeutics, a hybrid company, works hand-in-hand with longtime Homestead nursery Alpha Foliage. (Disclosure: Reporter Stacey Russell is related to Surterra’s director of public relations.) Together with Alpha, Surterra cultivates, extracts, packages, markets, and dispenses medical marijuana. (Surterra cannot distribute medical cannabis without a nursery partner because of Florida law.) It’s one of just two dispensaries authorized by the state. Surterra is based in Georgia, but because of the legalization of medical marijuana in Florida, the company has set up camp in Tampa and Tallahassee. New Times toured the Tallahassee cultivation center.
big-pharma1.jpegadmin | Toke of the Town

It currently sells a powerful opiate.

Here’s your daily round-up of pot-news, excerpted from the newsletter WeedWeek

The Intercept reports that Insys Therapeutics, the company that donated $500,000 to oppose REC in Arizona, is about to release a synthetic THC spray to relieve side effects associated with chemotherapy that would compete directly with MED. It’s been more widely noted that Insys’ only current product is an opioid spray. Insys noted in a 2007 SEC filing that legalization is a threat to its business.

Forbes surveys a list of cannabis-involved pharmaceutical companies that are takeover targets. Insys is among them.

010110_police.jpgadmin | Toke of the Town

“Verifying their stories is as difficult as finding your way through the forest at night.”

Here’s your daily round up of pot news, excerpted from the newsletter WeedWeek

A major investigation by The Center for Investigative Reporting’s Reveal project found “ dozens of accounts of sexual exploitation, abuse and trafficking” in the northern California grow regions. In Humboldt County alone 352 people went missing, more per capita than any other county in California.

Big-money investors are starting to see the upside in going “green.”elbud / Shutterstock.com

Big-money investors are starting to see the upside in going “green.”

Following Microsoft’s recent partnership with Kind Financial, Google may want to go green as well. John Lord, CEO of LivWell, a large vertically-integrated producer in Colorado, said the search giant had reached out to him. (On The Cannabist Show, Lord discusses the implications of industry-hated tax provision 280E.)

Venture capitalists are shaking off the stigma. The Bloomberg article contains the tidbit that New York’s health department uses Oracle software to monitor its MED program.

Jim Hagedorn, CEO of publicly-traded Scotts Miracle-Gro, said he want’s to “Invest, like, half a billion in the pot business…It is the biggest thing I’ve ever seen in lawn and garden.” Since 2015, Scotts has spent $255M acquiring companies that make soil, fertilizers, lighting and hydroponics. He pledges to invest $150M more this year.

Ohio is considering a cashless system — think pre-paid debit cards — for its newly legalized MED industry.

Colorado company Helix TCS acquired online wholesale platform Cannabase for an undisclosed sum. Wholesale prices are falling fast in Colorado.

Stock in Insys Therapeutics jumped after the FDA approved its cannabis-derived drug.

According to the Tampa Tribune, there are  15,000 businesses nationwide  providing ancillary products and services to the cannabis industry.
The Verdes Foundation is the  highest-grossing producer  in New Mexico. (The state’s MED industry is non-profit.) MED dispensaries in Hawaii can open next week but  most aren’t ready .
NORML executive director Allen St. Pierre reportedly resigned after 24 years. He will remain on the organization’s board. His interim replacement is treasurer Randy Quast.
Excerpted from the newsletter WeedWeek. Get your free and confidential subscription at WeedWeek.net.
1 2 3 17